Wellington Management Group LLP Raises Stock Holdings in Haleon PLC Sponsored ADR $HLN

Wellington Management Group LLP boosted its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 22.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,700,480 shares of the company’s stock after buying an additional 3,372,155 shares during the quarter. Wellington Management Group LLP owned approximately 0.41% of Haleon worth $192,428,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in HLN. Allspring Global Investments Holdings LLC raised its stake in shares of Haleon by 6.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company’s stock valued at $306,000 after acquiring an additional 1,749 shares during the last quarter. Oppenheimer & Co. Inc. increased its holdings in Haleon by 11.2% during the 1st quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company’s stock valued at $261,000 after purchasing an additional 2,564 shares during the period. Concurrent Investment Advisors LLC increased its holdings in Haleon by 32.9% during the 1st quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company’s stock valued at $168,000 after purchasing an additional 4,055 shares during the period. Mather Group LLC. raised its position in Haleon by 60.7% during the 1st quarter. Mather Group LLC. now owns 9,036 shares of the company’s stock valued at $93,000 after purchasing an additional 3,413 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in Haleon by 8.8% in the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company’s stock worth $131,000 after buying an additional 1,041 shares during the period. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

HLN has been the topic of several research analyst reports. Wall Street Zen cut Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. BNP Paribas upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, May 27th. Morgan Stanley raised shares of Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 target price for the company in a research report on Friday, May 9th. Barclays reiterated an “overweight” rating on shares of Haleon in a research report on Tuesday, May 6th. Finally, BNP Paribas Exane upgraded shares of Haleon from a “neutral” rating to an “outperform” rating and set a $13.40 price objective for the company in a report on Tuesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Stock Performance

Shares of HLN stock opened at $9.9050 on Thursday. The company’s fifty day moving average price is $9.97 and its 200-day moving average price is $10.20. The stock has a market cap of $44.46 billion, a PE ratio of 25.40, a price-to-earnings-growth ratio of 2.87 and a beta of 0.23. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42.

Haleon Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be issued a $0.0555 dividend. This represents a yield of 190.0%. This is a boost from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date is Friday, August 15th. Haleon’s dividend payout ratio is currently 28.21%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.